Journal
Frontiers in Oncology
Publication Date
1-1-2020
Volume
10
First Page
748
Document Type
Open Access Publication
DOI
10.3389/fonc.2020.00748
Rights and Permissions
Geraghty T, Rajagopalan A, Aslam R, Pohlman A, Venkatesh I, Zloza A, Cimbaluk D, DeNardo DG and Gupta V (2020) Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer. Front. Oncol. 10:748. doi: 10.3389/fonc.2020.00748 © 2020 Geraghty, Rajagopalan, Aslam, Pohlman, Venkatesh, Zloza, Cimbaluk, DeNardo and Gupta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Geraghty, Terese; Rajagopalan, Anugraha; Aslam, Rabail; Pohlman, Alexander; Venkatesh, Ishwarya; Zloza, Andrew; Cimbaluk, David; DeNardo, David G; and Gupta, Vineet, "Positive allosteric modulation of CD11b as a novel therapeutic strategy against lung cancer." Frontiers in Oncology. 10, 748 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9161
Supplementary Material
